Expression and significance of laminin receptor in squamous cell carcinoma of the tongue.
laminin receptor
prognostic factor
squamous cell carcinoma
tongue cancer
Journal
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
ISSN: 1600-0714
Titre abrégé: J Oral Pathol Med
Pays: Denmark
ID NLM: 8911934
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
revised:
19
08
2021
received:
31
05
2021
accepted:
03
09
2021
pubmed:
29
9
2021
medline:
9
3
2022
entrez:
28
9
2021
Statut:
ppublish
Résumé
Laminin receptor is a non-integrin cell-surface receptor that binds laminin present on the basement membrane. It has been reported to be associated with infiltration and metastasis of various malignant tumors. However, no studies regarding tongue cancer have been reported. This study aimed to clarify the role of laminin receptor in squamous cell carcinoma of the tongue. We performed immunohistochemical staining of specimens from 66 patients with squamous cell carcinoma of the tongue and assessed laminin receptor expression and clinicopathological factors. As epithelial-mesenchymal transition has been shown to be associated with infiltration and metastasis of malignant tumors, staining for E-cadherin, vimentin, and N-cadherin were also performed. Of 20 patients with postoperative recurrence, 14 exhibited high laminin receptor expression (p = 0.0025). Kaplan-Meier analysis revealed a significantly shorter time to postoperative recurrence for the high laminin receptor expression group than that for the low laminin receptor expression group (p = 0.0008). Based on multivariate analyses for postoperative recurrence, high laminin receptor expression was associated with poor prognosis (high expression vs. low expression; HR =3.19, 95% CI =0.92-11.08; p = 0.0682). There was a correlation between laminin receptor and N-cadherin (p = 0.0089) but not between laminin receptor and E-cadherin (p = 0.369) or vimentin (p = 0.4221). These results suggest that high laminin receptor expression is a useful prognostic factor for postoperative recurrence and may be a target for molecular therapy to treat squamous cell carcinoma of the tongue.
Sections du résumé
BACKGROUND
BACKGROUND
Laminin receptor is a non-integrin cell-surface receptor that binds laminin present on the basement membrane. It has been reported to be associated with infiltration and metastasis of various malignant tumors. However, no studies regarding tongue cancer have been reported. This study aimed to clarify the role of laminin receptor in squamous cell carcinoma of the tongue.
METHODS
METHODS
We performed immunohistochemical staining of specimens from 66 patients with squamous cell carcinoma of the tongue and assessed laminin receptor expression and clinicopathological factors. As epithelial-mesenchymal transition has been shown to be associated with infiltration and metastasis of malignant tumors, staining for E-cadherin, vimentin, and N-cadherin were also performed.
RESULTS
RESULTS
Of 20 patients with postoperative recurrence, 14 exhibited high laminin receptor expression (p = 0.0025). Kaplan-Meier analysis revealed a significantly shorter time to postoperative recurrence for the high laminin receptor expression group than that for the low laminin receptor expression group (p = 0.0008). Based on multivariate analyses for postoperative recurrence, high laminin receptor expression was associated with poor prognosis (high expression vs. low expression; HR =3.19, 95% CI =0.92-11.08; p = 0.0682). There was a correlation between laminin receptor and N-cadherin (p = 0.0089) but not between laminin receptor and E-cadherin (p = 0.369) or vimentin (p = 0.4221).
CONCLUSION
CONCLUSIONS
These results suggest that high laminin receptor expression is a useful prognostic factor for postoperative recurrence and may be a target for molecular therapy to treat squamous cell carcinoma of the tongue.
Substances chimiques
Cadherins
0
Laminin
0
Receptors, Laminin
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
263-271Informations de copyright
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Sacco A, Cohen E. Current treatment options for recurrent or metastatic head and neck squamous cell carcinoma. J Clin Oncol. 2015;39:3305-3315.
Nadji M, Nassiri M, Fresno M, Terzian E, Morales AR. Laminin receptor in lymph node negative breast carcinoma. Cancer. 1999;85:432-436.
Al-Saleh W, Delvenne P, Van den brule FA, et al. Expression of the 67 kD laminin receptor in human cervical preneoplastic and neoplastic squamous epithelial lesions: An immunohistochemical study. J Pathol. 1997;181:287-293.
Sanjuán X, Fernández PL, Miquel R, et al. Overexpression of the 67-kD laminin receptor correlates with tumour progression in human colorectal carcinoma. J Pathol. 1996;179:376-380.
De Manzoni G, Guglielmi A, VerlatoG, et al. Prognostic significance of 67-kDa laminin receptor expression in advanced gastric cancer. Oncology. 1998;55:456-460.
Ozaki I, Yamamoto K, Mizuta T, et al. Differential expression of laminin receptors in human hepatocellular carcinoma. Gut. 1998;43:837-842.
Fontanini G, Vignati S, Chiné S, et al. 67-Kilodalton laminin receptor expression correlates with worse prognostic indicators in non-small cell lung carcinomas. Clin Cancer Res. 1997;3:227-231.
Zhou L, Xie M, Zhou JQ, Tao L. 67-kDa laminin receptor in human laryngeal squamous cell carcinoma. Laryngoscope. 2006;116:28-32.
Paolillo M, Schinelli S. Extracellular matrix alterations in metastatic processes. Int J Mol Sci. 2019;20:4979.
Wang Y, Dong H, Xu M, et al. 37-kDa laminin receptor precursor promotes lung adenocarcinoma cell invasion and metastasis by epithelial-to-mesenchymal transition. Cancer Gene Ther. 2014;21:150-157.
Brierley JD, Gospodarowicz MK, Wittekind C, et al. TNMclassification of malignant tumours, 8th ed. John Wiley & Sons; 2017:18-21.
Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 1998;11:155-168.
Li D, Chen J, Gao Z, et al. 67-kDa laminin receptor in human bile duct carcinoma. Eur Surg Res. 2009;42:168-173.
Gröbe A, Eichhorn W, Fraederich M, et al. Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma. J Oral Pathol Med. 2014;43:205-210.
Carlos De Vicente J, Herrero-Zapatero A, Frenso MF, López-Arranz JS. Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance. Oral Oncol. 2002;38:301-308.
Dong C, Ye DX, Zhang WB, et al. Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma. J Oral Pathol Med. 2015;44:353-360.
Pontes HAR, Pontes FSC, de Jesus AS, et al. p-Akt and its relationship with clinicopathological features and survival in oral squamous cell carcinoma: an immunohistochemical study. J Oral Pathol Med. 2015;44:532-537.
Scheiman J, Tseng JC, Zheng Y, Meruelo D. Multiple functions of the 37/67-kd laminin receptor make it a suitable target for novel cancer gene therapy. Mol Ther. 2010;18:63-74.
Kumazoe M, Hiroi S, Tanimoto Y, et al. Cancer cell selective probe by mimicking EGCG. Biochem Biophys Res Commun. 2020;525:974-981.
Berno V, Porrini D, Castiglioni F, et al. The 67 kDa laminin receptor increases tumor aggressiveness by remodeling laminin-1. Endocr Relat Cancer. 2005;12:393-406.
Ardini E, Sporchia B, Pollegioni L, et al. Identification of a novel function for 67-kDa laminin receptor: Increase in laminin degradation rate and release of motility fragments. Cancer Res. 2002;62;1321-1325.22.
Rees JRE, Onwuegbusi BA, Save VE, et al. In vivo and in vitro evidence for transforming growth factor-β1-mediated epithelial to mesenchymal transition in esophageal adenocarcinoma. Cancer Res. 2006;66:9583-9590.
Ellenrieder V, Hendler SF, Boeck W, et al. Transforming growth factor β1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. Cancer Res. 2001;61:4222-4228.
Gumireddy K, Li A, Gimotty PA, et al. KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer. Nat Cell Biol. 2009;11:1297-1304.
Hou J, Ge C, Cui M, et al. Pigment epithelium-derived factor promotes tumor metastasis through an interaction with laminin receptor in hepatocellular carcinomas. Cell Death Dis. 2017;8:e2969.
Yang J, Antin P, Berx G, et al. Guidelines and definitions for research on epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2020;21:341-352.
Martignone S, Ménard S, Bufalino R, et al. Prognostic significance of the 67-kilodalton laminin receptor expression in human breast carcinomas. J Natl Cancer Inst. 1993;85:398-402.
Waltregny D, de Leval L, Ménard S, et al. Independent prognostic value of the 67-kd laminin receptor in human prostate cancer. J Natl Cancer Inst. 1997;89:1224-1227.
Hano K, Hatano K, Saigo C, et al. An adiponectin paralog protein, CTRP6 decreased the proliferation and invasion activity of oral squamous cell carcinoma cells: possible interaction with laminin receptor pathway. Mol Biol Rep. 2019;46:4967-4973.
Kumazoe M, Sugihara K, Tsukamoto S, et al. 67-kDa laminin receptor increases cGMP to induce cancer-selective apoptosis. J Clin Invest. 2013;123:787-799.